Tuesday, September 21, 2021
- Advertisement -spot_img


Solidarity Trial

WHO discontinues hydroxychloroquine, lopinavir/ritonavir trial for Covid-19

These interim trial results show that hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalized Covid-19 patients when compared to standard of care.

WHO includes hydroxychloroquine in solidarity trial again

At a press conference in the WHO headquarters in Geneva, Director General Tedros Adhanom Ghebreyesus said: "On the basis of the available mortality data, the members of the committee recommended that there are no reasons to modify the trial protocol.

WHO suspends hydroxychloroquine clinical trial on COVID-19 patients

According to the WHO chief, The Lancet medical journal on May 22 had published an observational study on HCQ and chloroquine and its effects on COVID-19 patients that have been hospitalised.

Latest news

- Advertisement -spot_img
Telangana Today